Donald Trump releases cardiovascular test data and other medical information

Presidential candidate Donald Trump released his medical records Sept. 14, which revealed that he takes rosuvastatin to treat high cholesterol.

Harold N. Bornstein, MD, of Lenox Hill Hospital in New York and Trump’s personal physician since 1980, revealed Trump’s medical information in a letter dated Sept. 13.

Trump had a total cholesterol level of 169 mg/dL, a high-density lipoprotein level of 63 mg/dL, a low-density lipoprotein level of 94 mg/dL and a triglycerides level of 61 mg/dL. His blood pressure was 116/70 mm Hg.

Bornstein also wrote that an EKG and chest x-ray performed on April 14 and a transthoracic echocardiogram performed on Dec. 16, 2014, were within the normal range. He added that Trump has no family history of premature cardiac or neoplastic disease.

“In summary, Mr. Trump is in excellent physical health,” Bornstein wrote.

Hillary Clinton, the Democratic Presidential nominee, released her medical information Sept. 13. Lisa Bardack, MD, Clinton’s personal physician, wrote in a letter that Clinton was “in excellent medical condition” despite being diagnosed with pneumonia a few days earlier.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.